Results 131 to 140 of about 37,717 (247)

Diagnostic Performance of Conventional Ultrasound Combined With Calcification Parameters in Soft Tissue Masses With Calcification: A Retrospective Study

Sonography, Volume 13, Issue 3, September 2026.
ABSTRACT Objective This study aimed to develop and validate an ultrasound‐based model integrating conventional ultrasound and calcification patterns (US‐CAL) for distinguishing benign from malignant calcified soft tissue masses. Methods This retrospective study analyzed 101 pathologically confirmed soft tissue masses (78 benign, 23 malignant) that ...
Lu Xie, Yun Tian, Nan Zhuang, Feng Wang, Heng L.V., Yusen Zhang, Chenyang Zhao, Wangjie Wu, Zhaoling Yi, Ennuo Ma, Ruixiang Yin, Desheng Sun, Haiqin Xie   +12 more
wiley   +1 more source

Successful treatment of refractory focal eosinophilic myositis with extra-ocular muscle involvement using tocilizumab: a case report. [PDF]

Front Immunol
Liu H, Li Q, Ouyang X, Chen S, Liang H, Ye Y, Cao H, Xue Y, Dai L.   +8 more
europepmc   +1 more source

A Rare Case of Cutaneous Extramedullary Hematopoiesis in Chronic Myeloid Leukemia

Journal of Cutaneous Pathology, Volume 53, Issue 9, Page 767-771, September 2026.
ABSTRACT Cutaneous extramedullary hematopoiesis (CEH) is a rare manifestation of extramedullary hematopoiesis (EMH), a process typically associated with fetal development or myeloproliferative neoplasms. EMH most commonly involves the spleen, liver, and lymph nodes, with CEH being exceedingly rare in chronic myeloid leukemia (CML).
Bennett Christie‐Nguyen, Hanadi El Achi, Levani Iashvili, Amer Wahed, Brenda Mai, Jacob Armstrong   +5 more
wiley   +1 more source

Triple-M Overlap Syndrome Associated with Immune Checkpoint Inhibitors: A FAERS Pharmacovigilance Analysis. [PDF]

Healthcare (Basel)
Alshamsan B, Ng TL.
europepmc   +1 more source

The 2025 ATS/ERS update of the international multidisciplinary classification of the interstitial pneumonias: implications for the pathologist

Histopathology, Volume 89, Issue 3, Page 403-425, September 2026.
This review highlights changes relevant to pathologists in the updated multidisciplinary classification of interstitial pneumonias. Changes include expansion beyond idiopathic disease, subclassification as interstitial (fibrotic vs non‐fibrotic) and alveolar filling disorders, expansion to include additional patterns (e.g.
Andrew G Nicholson, Wendy A. Cooper, Aurelie Fabre, William Travis, Lida P. Hariri, Ayodeji Adegunsoye, Sara Piciucchi, Christopher J Ryerson   +7 more
wiley   +1 more source

Clinical features of dengue-associated myositis in children: a retrospective study. [PDF]

J Pediatr (Rio J)
Birne RO, Neri MA, Rossetti CA, Sena MO, Duarte LPR, Takenami LI, Goulardins JB, Matos MA.   +7 more
europepmc   +1 more source

COVID‐19 Vaccination Is Not Associated With the Development of Idiopathic Inflammatory Myositis in US Veterans

Arthritis Care &Research, Volume 78, Issue 8, Page 1078-1085, August 2026.
Objective Several case reports have proposed a potential association between COVID‐19 vaccination and the subsequent development of idiopathic inflammatory myositis (IIM). This study examined prior COVID‐19 vaccination in US veterans who developed new‐onset IIM compared to those without new‐onset IIM.
Caleb Hernández, Naomi Schlesinger, Jorge Rojas, Jessica A. Walsh, Tawnie J. Braaten, Gary A. Kunkel, Makoto Jones, Brian C Sauer, Julio Facelli, Grant W. Cannon, Dorota Lebiedz‐Odrobina   +10 more
wiley   +1 more source

Orbital myositis last year and now Crohn's disease: A case report of a rare association. [PDF]

SAGE Open Med Case Rep
Patel A, Beltran G, Sharma N, Patel J, Allen K.   +4 more
europepmc   +1 more source

Beyond Glucocorticoids: The Current Landscape and Prospects for Treating Immune Checkpoint Inhibitor‐Induced Autoimmunity

ACR Open Rheumatology, Volume 8, Issue 8, August 2026.
The rapid integration of immune checkpoint inhibitors (ICIs) into standard oncology protocols has birthed a new frontier in clinical rheumatology: immune‐related adverse events (irAEs). By disrupting the programmed cell death‐1 (PD‐1)/PD‐L1 and cytotoxic T‐lymphocyte‐associated protein 4 (CTLA‐4) axes to restore antitumor T cell activity, these ...
Xizi Hu, Ji Eun Ryoo, Brian S. Henick, Adam Mor   +3 more
wiley   +1 more source

Tofacitinib for Calcinosis Cutis Associated With Juvenile Dermatomyositis: An Open‐Label Single‐Arm Study

ACR Open Rheumatology, Volume 8, Issue 8, August 2026.
Objective Calcinosis cutis (CC) is dystrophic calcification affecting 20% to 40% of patients with juvenile dermatomyositis (JDM). Management of CC is often challenging owing to its being refractory to usual therapeutic options. Type I interferon (IFN)‐mediated immune dysregulation may be involved in the pathogenic role in CC, suggesting that altering ...
Pragati Jain, Supraja Laguduva Mohan, Shivani Kaushik, Rakesh Deepak, Dibyanshu Mishra, MA Khan, Vishal Gupta, Priyanka Naranje, AV Ramanan, Rakesh Lodha, Manisha Jana, Narendra Kumar Bagri   +11 more
wiley   +1 more source